Your search returned 76 studies:
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallo
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Los Angeles, California
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallo
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Los Angeles, California
- Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Prima
Conditions: Brenner Tumor - Fallopian Tube Cancer - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated A
Location: Los Angeles, California
- Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblasto
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Extragonadal Germ Cell Tumor - Liver Cancer - Neuroblastoma - Ototoxicity - Ovarian Cancer - Sarcoma
Location: Los Angeles, California
- Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblasto
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Extragonadal Germ Cell Tumor - Liver Cancer - Neuroblastoma - Ototoxicity - Ovarian Cancer - Sarcoma
Location: Los Angeles, California
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: Los Angeles, California
- Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Conditions: Ovarian Cancer
Location: Los Angeles, California
- Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Ovarian Cancer
Conditions: Tumor - Ovarian Cancer
Location: Los Angeles, California
- Veliparib in Treating Patients With Malignant Solid Tumors That Did Not Respond to Previous Therapy
Conditions: BRCA1 Mutation Carrier - BRCA2 Mutation Carrier - Estrogen Receptor-negative Breast Cancer - Fallopian Tube Cancer - HER2-negative Breast Cancer - Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2) - Male Breast Cancer - Primary Peritoneal Cavity Cancer - Pr
Location: Los Angeles, California
- Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer
Conditions: Adult Primary Hepatocellular Carcinoma - Advanced Adult Primary Liver Cancer - Endometrial Papillary Serous Carcinoma - Localized Unresectable Adult Primary Liver Cancer - Metastatic Gastrointestinal Carcinoid Tumor - Ovarian Carcinosarcoma - Ovarian Endo
Location: Los Angeles, California
- Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnos
Conditions: Ovarian Mucinous Cystadenocarcinoma - Ovarian Mucinous Cystadenoma With Proliferating Activity - Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Stage IA Fallopian Tube Cancer - Stage IA Ovarian Epithelial Cancer - Stage IB Fallopi
Location: Los Angeles, California
- Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnos
Conditions: Ovarian Mucinous Cystadenocarcinoma - Ovarian Mucinous Cystadenoma With Proliferating Activity - Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Stage IA Fallopian Tube Cancer - Stage IA Ovarian Epithelial Cancer - Stage IB Fallopi
Location: Los Angeles, California
- Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, Peritoneal Cancer, or Recurrent T
Conditions: Breast Cancer - Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
Location: Los Angeles, California
- Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Can
Conditions: Ovarian Clear Cell Cystadenocarcinoma - Stage III Ovarian Epithelial Cancer - Stage IV Ovarian Epithelial Cancer
Location: Los Angeles, California
- Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer
Conditions: Healthy, no Evidence of Disease - Hereditary Breast/Ovarian Cancer - BRCA1 - Hereditary Breast/Ovarian Cancer - BRCA2
Location: Los Angeles, California
- TRINOVA-2: Trebananib in Ovarian Cancer-2
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cancer
Location: Los Angeles, California
- TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cancer
Location: Los Angeles, California
- Cvac as Maintenance Treatment in Patients With EOC in Complete Remission Following First-Line Chemotherapy
Conditions: Epithelial Ovarian Cancer
Location: Los Angeles, California
- SGI-110 in Combination With Carboplatin in Ovarian Cancer
Conditions: Ovarian Cancer
Location: Los Angeles, California
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallo
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Los Angeles, California
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallo
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Los Angeles, California
- Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors
Conditions: Brain and Central Nervous System Tumors - Extragonadal Germ Cell Tumor - Ovarian Cancer - Teratoma - Testicular Germ Cell Tumor
Location: Los Angeles, California
- Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Prima
Conditions: Brenner Tumor - Fallopian Tube Cancer - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated A
Location: Los Angeles, California
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: Los Angeles, California
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: Los Angeles, California
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: Los Angeles, California
- Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer - Psychosocial Effects of Cancer and Its Treatment
Location: Los Angeles, California
- Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Rec
Conditions: Cognitive/Functional Effects - Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Los Angeles, California
- Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Rec
Conditions: Cognitive/Functional Effects - Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Los Angeles, California
- Cediranib and Olaparib in Combination for Recurrent Ovarian or Triple-Negative Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - HER2-negative Breast Cancer - Ovarian Endometrioid Adenocarcinoma - Ovarian Papillary Serous Carcinoma - Ovarian Serous Cystadenocarcinoma - Progesterone Receptor-negative Breast Cancer - Recurrent Breast Cancer
Location: Los Angeles, California
- A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women
Conditions: Epithelial Ovarian Cancer
Location: Los Angeles, California
- Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary P
Conditions: Brenner Tumor - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated Adenocarcinoma - Stage II
Location: Los Angeles, California
- Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Conditions: Ovarian Cancer
Location: Long Beach, California
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallo
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Burbank, California
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallo
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Long Beach, California
- Stress, Immunity and Cervical Cancer: Biobehavioral Outcomes
Conditions: Ovarian Cancer
Location: Orange, California
- Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Prima
Conditions: Brenner Tumor - Fallopian Tube Cancer - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated A
Location: Long Beach, California
- Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity
Conditions: Ovarian Cancer - Peritoneal Cavity Cancer - Unspecified Adult Solid Tumor, Protocol Specific
Location: Duarte, California
- Veliparib in Treating Patients With Malignant Solid Tumors That Did Not Respond to Previous Therapy
Conditions: BRCA1 Mutation Carrier - BRCA2 Mutation Carrier - Estrogen Receptor-negative Breast Cancer - Fallopian Tube Cancer - HER2-negative Breast Cancer - Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2) - Male Breast Cancer - Primary Peritoneal Cavity Cancer - Pr
Location: Duarte, California
- Veliparib in Treating Patients With Malignant Solid Tumors That Did Not Respond to Previous Therapy
Conditions: BRCA1 Mutation Carrier - BRCA2 Mutation Carrier - Estrogen Receptor-negative Breast Cancer - Fallopian Tube Cancer - HER2-negative Breast Cancer - Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2) - Male Breast Cancer - Primary Peritoneal Cavity Cancer - Pr
Location: South Pasadena, California
- Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian T
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Burbank, California
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: Burbank, California
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: Sylmar, California
- Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer
Conditions: Adult Primary Hepatocellular Carcinoma - Advanced Adult Primary Liver Cancer - Endometrial Papillary Serous Carcinoma - Localized Unresectable Adult Primary Liver Cancer - Metastatic Gastrointestinal Carcinoid Tumor - Ovarian Carcinosarcoma - Ovarian Endo
Location: Pasadena, California
- AMG 102 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
Location: Burbank, California
- Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian S
Conditions: Ovarian Cancer
Location: Burbank, California
- Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian S
Conditions: Ovarian Cancer
Location: Sylmar, California
- Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Rec
Conditions: Cognitive/Functional Effects - Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Burbank, California
- Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnos
Conditions: Ovarian Mucinous Cystadenocarcinoma - Ovarian Mucinous Cystadenoma With Proliferating Activity - Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Stage IA Fallopian Tube Cancer - Stage IA Ovarian Epithelial Cancer - Stage IB Fallopi
Location: Burbank, California
- A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women
Conditions: Epithelial Ovarian Cancer
Location: Duarte, California
- Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Conditions: Ovarian Cancer
Location: Burbank, California
- Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Can
Conditions: Ovarian Clear Cell Cystadenocarcinoma - Stage III Ovarian Epithelial Cancer - Stage IV Ovarian Epithelial Cancer
Location: Burbank, California
- Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer
Conditions: Healthy, no Evidence of Disease - Hereditary Breast/Ovarian Cancer - BRCA1 - Hereditary Breast/Ovarian Cancer - BRCA2
Location: Duarte, California
- Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer
Conditions: Healthy, no Evidence of Disease - Hereditary Breast/Ovarian Cancer - BRCA1 - Hereditary Breast/Ovarian Cancer - BRCA2
Location: Sylmar, California
- Study of BMN 673, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors
Conditions: Advanced or Recurrent Solid Tumors - Breast Neoplasms - Ovarian Cancer, Epithelial - Ewing Sarcoma - Small Cell Lung Carcinoma - Prostate Cancer - Pancreas Cancer
Location: Santa Monica, California
- Bevacizumab With or Without Fosbretabulin Tromethamine in Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavi
Conditions: Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Primary Peritoneal Cavity Cancer
Location: Burbank, California
- Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney
Conditions: Extensive Stage Small Cell Lung Cancer - Recurrent Borderline Ovarian Surface Epithelial-stromal Tumor - Recurrent Breast Cancer - Recurrent Melanoma - Recurrent Non-small Cell Lung Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Ovarian Germ Cel
Location: Duarte, California
- Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney
Conditions: Extensive Stage Small Cell Lung Cancer - Recurrent Borderline Ovarian Surface Epithelial-stromal Tumor - Recurrent Breast Cancer - Recurrent Melanoma - Recurrent Non-small Cell Lung Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Ovarian Germ Cel
Location: South Pasadena, California
- Ovarian Reserve Testing in Female Young Adult Cancer Survivors
Conditions: Cancer - Infertility
Location: San Diego, California
- Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal
Conditions: Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Primary Peritoneal Cavity Cancer
Location: Burbank, California
- TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cancer
Location: Burbank, California
- TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cancer
Location: Long Beach, California
- Cvac as Maintenance Treatment in Patients With EOC in Complete Remission Following First-Line Chemotherapy
Conditions: Epithelial Ovarian Cancer
Location: Downey, California
- VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal C
Conditions: Epithelial Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer
Location: Long Beach, California
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallo
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Orange, California
- Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Prima
Conditions: Brenner Tumor - Fallopian Tube Cancer - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated A
Location: Orange, California
- Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Ovarian Cancer
Conditions: Tumor - Ovarian Cancer
Location: Newport Beach, California
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: Orange, California
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: Orange, California
- Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnos
Conditions: Ovarian Mucinous Cystadenocarcinoma - Ovarian Mucinous Cystadenoma With Proliferating Activity - Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Stage IA Fallopian Tube Cancer - Stage IA Ovarian Epithelial Cancer - Stage IB Fallopi
Location: Orange, California
- Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Conditions: Ovarian Cancer
Location: Azusa, California
- Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavit
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Orange, California
- A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
Conditions: Epithelial Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
Location: Corona, California
- Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal
Conditions: Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Primary Peritoneal Cavity Cancer
Location: Newport Beach, California
- TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cancer
Location: Corona, California
- Cvac as Maintenance Treatment in Patients With EOC in Complete Remission Following First-Line Chemotherapy
Conditions: Epithelial Ovarian Cancer
Location: Orange, California
|